<DOC>
	<DOCNO>NCT01464424</DOCNO>
	<brief_summary>The purpose study assess efficacy tolerability travoprost 0.004 % vs. bimatoprost 0.01 % office hour period ( 4 pm 8 pm ) subject open-angle glaucoma ocular hypertension 6 week treatment .</brief_summary>
	<brief_title>Assessment Intraocular Pressure ( IOP ) Control Subjects With Open-Angle Glaucoma Ocular Hypertension Treated With Travoprost 0.004 % ( TRAVATAN® Z ) Bimatoprost 0.01 % ( LUMIGAN® )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Clinical diagnosis openangle glaucoma ( OAG ) ocular hypertension ( OHT ) least one eye . Nonstudy eye : Intraocular pressure ( IOP ) able control pharmacologic therapy study medicine alone . Willing discontinue use ocular hypotensive medication prior receive study medication entire course study . Able follow instruction , self instill study article , attend study visit . Bestcorrected Snellen visual acuity 20/200 good eye . Sign Ethics Committee review approve informed consent form . Other protocoldefined inclusion criterion may apply . Known medical history allergy , hypersensitivity poor tolerance component preparation use study . Any abnormality prevent applanation tonometry either eye . Dry eye previously currently treat punctal plug , punctal cautery , Restasis® , topical ocular corticosteroid . Concurrent infectious/noninfectious conjunctivitis , keratitis uveitis either eye . Intraocular conventional laser surgery &gt; 3 month prior consent . Risk visual field visual acuity worsen consequence participation study , investigator 's best judgment . Progressive retinal optic nerve disease cause . Use systemic medication know affect IOP stable course least 7 day prior Screening anticipate change dosage course study . Any clinically significant , serious , severe medical condition . Women childbearing potential pregnant , lactating , use reliable mean birth control . Participation study within 30 day prior Screening . Use systemic ( oral ) , injectable topical steroid . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>Open-Angle Glaucoma</keyword>
	<keyword>Intraocular Pressure</keyword>
</DOC>